相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells
Julie Girouard et al.
GYNECOLOGIC ONCOLOGY (2013)
Pharmacokinetics, Metabolism, and Excretion of the Glycogen Synthase Kinase-3 Inhibitor LY2090314 in Rats, Dogs, and Humans: A Case Study in Rapid Clearance by Extensive Metabolism with Low Circulating Metabolite Exposure
Maciej J. Zamek-Gliszczynski et al.
DRUG METABOLISM AND DISPOSITION (2013)
TARGETING THE AKT/GSK3β/CYCLIN D1/CDK4 SURVIVAL SIGNALING PATHWAY FOR ERADICATION OF TUMOR RADIORESISTANCE ACQUIRED BY FRACTIONATED RADIOTHERAPY
Tsutomu Shimura et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Moderate GSK-3β inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy
Mien V. Hoang et al.
ANGIOGENESIS (2010)
Glycogen Synthase Kinase-3β: A Prognostic Marker and a Potential Therapeutic Target in Human Bladder Cancer
Sei Naito et al.
CLINICAL CANCER RESEARCH (2010)
Targeting the PI3K signaling pathway in cancer
Kwok-Kin Wong et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Platelet-derived Growth Factor-DD Targeting Arrests Pathological Angiogenesis by Modulating Glycogen Synthase Kinase-3β Phosphorylation
Anil Kumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein
M. R. Abedini et al.
ONCOGENE (2010)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
Pharmacologic modulation of glycogen synthase kinase-3β promotes p53-dependent apoptosis through a direct bax-mediated mitochondrial pathway in colorectal cancer cells
J Tan et al.
CANCER RESEARCH (2005)
Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3β in colorectal cancer cells
JC Ghosh et al.
CLINICAL CANCER RESEARCH (2005)
Glycogen synthase kinase-3 is an endogenous inhibitor of snail transcription: implications for the epithelial-mesenchymal transition
RE Bachelder et al.
JOURNAL OF CELL BIOLOGY (2005)
Akt/PKB signaling mechanisms in cancer and chemoresistance
D Kim et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
PWB Derksen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
MJ Byrne et al.
ANNALS OF ONCOLOGY (2004)
Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage
O David et al.
CLINICAL CANCER RESEARCH (2004)
GSK3 inhibitors: Development and therapeutic potential
P Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition
BHP Zhou et al.
NATURE CELL BIOLOGY (2004)
p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis
PS Kho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
GSK-3: tricks of the trade for a multi-tasking kinase
BW Doble et al.
JOURNAL OF CELL SCIENCE (2003)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
